EUVIMEDEUVIMED entdecken
Crossref

A beta oligomerization A Therapeutic Target for Alzheimers Disease

D. Howlett

Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents · 2001

DOI: 10.2174/1568013013359140 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents, 2001. Verfasst von D. Howlett. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Howlett, D. (2001). A beta oligomerization A Therapeutic Target for Alzheimers Disease. Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents. https://doi.org/10.2174/1568013013359140

Vancouver

Howlett D. A beta oligomerization A Therapeutic Target for Alzheimers Disease. Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents. 2001. doi:10.2174/1568013013359140

BibTeX
@article{Howlett2001,
  author = {Howlett, D.},
  title = {A beta oligomerization A Therapeutic Target for Alzheimers Disease},
  journal = {Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents},
  year = {2001},
  doi = {10.2174/1568013013359140}
}
Kostenlos starten →